Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · iShares

IBRN Holdings: What iShares Neuroscience and Healthcare ETF Owns

Ticker IBRN · Since 2022-08-24 · · Holdings as of Jul 31, 2026

Expense ratio
0.47%$47/yr per $10k
1-yr return
−2.7%as of Dec 2024
Net assets
$5.5Mall share classes
Holdings
78

Bottom line

What does IBRN hold?

IBRN held 78 positions as of Jul 31, 2026. Its largest holding is BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares at 14.64% of the fund, and the top 10 positions add up to 56.2%. By asset type it is 96% stocks, 15% cash & short-term funds, 4% other.

Updated Sep 23, 2026

IBRN top 25 holdings

#HoldingType% of fundValue
1 BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares
BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY
Cash & short-term funds 14.64%$802.9K
2 Dianthus Therapeutics Inc
DIANTHUS THERAPEUTICS INC
Stocks 5.34%$292.9K
3 Xenon Pharmaceuticals Inc
XENON PHARMACEUTICALS INC
Stocks 4.87%$267.2K
4 Praxis Precision Medicines Inc
PRAXIS PRECISION MEDICINES INC
Stocks 4.87%$267.2K
5 Acadia Pharmaceuticals Inc.
ACADIA PHARMACEUTICALS INC
Stocks 4.69%$257.4K
6 Arrowhead Pharmaceuticals, Inc.
ARROWHEAD PHARMACEUTICALS INC
Stocks 4.65%$255.3K
7 Alkermes Public Limited Company
ALKERMES PLC
Stocks 4.60%$252.4K
8 Scholar Rock Holding Corp
SCHOLAR ROCK HOLDING CORP
Stocks 4.29%$235.5K
9 Biogen Inc.
BIOGEN INC
Stocks 4.18%$229.1K
10 Neurocrine Biosciences, Inc.
NEUROCRINE BIOSCIENCES INC
Stocks 4.09%$224.3K
11 argenx SE
ARGENX SE
Other 3.86%$211.7K
12 Ptc Therapeutics, Inc.
PTC THERAPEUTICS INC
Stocks 3.85%$211.4K
13 Axsome Therapeutics, Inc.
AXSOME THERAPEUTICS INC
Stocks 3.77%$206.9K
14 Denali Therapeutics Inc
DENALI THERAPEUTICS INC
Stocks 3.67%$201.4K
15 Dyne Therapeutics, Inc
DYNE THERAPEUTICS INC
Stocks 3.56%$195.5K
16 Edgewise Therapeutics Inc
EDGEWISE THERAPEUTICS INC
Stocks 3.23%$177.4K
17 Supernus Pharmaceuticals, Inc.
SUPERNUS PHARMACEUTICALS INC
Stocks 2.61%$142.9K
18 AxoGen, Inc.
AXOGEN INC
Stocks 2.34%$128.4K
19 SK Biopharmaceuticals Co Ltd
SK BIOPHARMACEUTICALS CO LTD
Stocks 2.30%$126.1K
20 H. Lundbeck A/s
H LUNDBECK A S
Stocks 1.84%$100.8K
21 Biohaven Ltd
BIOHAVEN LTD
Stocks 1.82%$99.6K
22 Sarepta Therapeutics, Inc.
SAREPTA THERAPEUTICS INC
Stocks 1.61%$88.5K
23 BioArctic AB
BIOARCTIC AB
Stocks 1.56%$85.6K
24 Taysha Gene Therapies Inc
TAYSHA GENE THERAPIES INC
Stocks 1.50%$82.0K
25 Neuren Pharmaceuticals Ltd
NEUREN PHARMACEUTICALS LTD
Stocks 1.48%$81.1K

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026

Asset mix

Stocks95.5%
Cash & short-term funds14.8%
Other4.4%

Country exposure

CA5.5%
CH1.8%
DK1.8%
FR0.8%
IE5.0%
JP0.8%
KR2.4%
NL3.9%
NZ1.5%
SE2.4%